UBS Maintains Neutral on Edgewell Personal Care, Lowers Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Peter Grom maintains a Neutral rating on Edgewell Personal Care (NYSE:EPC) but lowers the price target from $42 to $40.
August 07, 2024 | 4:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS analyst Peter Grom maintains a Neutral rating on Edgewell Personal Care (NYSE:EPC) and lowers the price target from $42 to $40.
The Neutral rating suggests that UBS does not see significant upside or downside potential in the short term. The lowered price target from $42 to $40 indicates a slightly more cautious outlook, but it is not a drastic change. Therefore, the short-term impact on EPC's stock price is likely to be neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100